Objectives

After participating in this educational activity, attendees should be able to:
1. Understand the balance between conventional surgical pathology and genomic pathology
2. Discuss relative cost benefits of these competing technologies
3. Appreciate the impact of societal shifts associated with personalized medicine and its "promise"

Faculty

Christopher D. M. Fletcher, MD, FRCPath
Professor and Vice Chair, Anatomic Pathology
Department of Pathology
Brigham & Women's Hospital

Faculty Disclosure

The design and content of Baystate Continuing Interprofessional Education ( CE ) activities support quality improvement in healthcare and provide fair and balanced views of therapeutic options.  Faculty or planner conflicts of interest are resolved before the educational activity.

None of the members of the faculty and planning committee for this educational event have commercial relationships with any entity producing, marketing, re-selling or distributing health care goods and services consumed by or used on patients.